Induction of remission with tacrolimus in a patient with severe acute, cortisone refractory ulcerative colitis and severe Covid-19 pneumonia: a case reportCase Report Published on 2022-01-152022-10-27 Journal: BMC Gastroenterology [Category] COVID-19, [키워드] acute respiratory syndrome adjusted Admission Case report clinical response Clinical symptoms clinician coronavirus cortisone cortisone therapy Course COVID-19 COVID-19 pneumonia defined discharged dose High-dose hospital IBD Immunosuppression IMPROVE increased risk induction infected patient Infection Inflammatory Inflammatory bowel disease inhibitor initiated intravenous managing medication outbreak pandemic Patient patients positive Prednisolone presenting regimen risk SARS-CoV-2 severe coronavirus disease Symptoms the patient therapeutic option therapy treat Treatment ulcerative colitis viral infection viral reactivation was tested [DOI] 10.1186/s12876-022-02094-3 PMC 바로가기 [Article Type] Case Report
Induction of remission with tacrolimus in a patient with severe acute, cortisone refractory ulcerative colitis and severe Covid-19 pneumonia: a case reportCase Report Published on 2022-01-152022-10-27 Journal: BMC Gastroenterology [Category] Coronavirus, COVID-19, Fulltext, SARS, [키워드] acute respiratory syndrome adjusted Admission Case report clinical response Clinical symptoms clinician coronavirus cortisone cortisone therapy Course COVID-19 COVID-19 pneumonia defined discharged dose High-dose hospital IBD Immunosuppression IMPROVE increased risk induction infected patient Infection Inflammatory Inflammatory bowel disease inhibitor initiated intravenous managing medication outbreak pandemic Patient patients positive Prednisolone presenting regimen risk SARS-CoV-2 severe coronavirus disease Symptoms the patient therapeutic option therapy treat Treatment ulcerative colitis viral infection viral reactivation was tested [DOI] 10.1186/s12876-022-02094-3 PMC 바로가기 [Article Type] Case Report
Tofacitinib for Biologic-Experienced Hospitalized Patients with Acute Severe Ulcerative Colitis: A Retrospective Case-Control StudyArticle Published on 2022-01-082024-09-04 Journal: Clinical gastroenterology and hepatology : the off [Category] 대상포진, [키워드] colectomy Tofacitinib ulcerative colitis [DOI] 10.1016/j.cgh.2021.05.038 PMC 바로가기 [Article Type] Article
Ambulatory care management of 69 patients with acute severe ulcerative colitis in comparison to 695 inpatients: insights from a multicentre UK cohort study695명의 입원 환자와 비교하여 급성 중증 궤양성 대장염 환자 69명의 외래 치료 관리: 영국 다기관 코호트 연구의 통찰력Multicenter Study Published on 2022-01-012022-09-11 Journal: BMJ open gastroenterology [Category] SARS, 치료기술, [키워드] acceptability age ambulatory Ambulatory care ambulatory patient ambulatory patients Analysis Aside bowel Care Cohort cohort study cohorts colectomy collected Corticosteroid COVID-19 criteria detect Diagnosis discharged disease disease phenotype Effectiveness Eligible patients evaluated flexible flexible sigmoidoscopy Follow-up Health Service health service research hospital Hospital admission hospital management hospitalised IBD IBD clinical index Inflammatory Inflammatory bowel disease intravenous less management Mortality multicentre no significant difference no significant differences outcome outcome measure Pathways Patient patients treated performed phenotype physician post-hoc analysis Primary outcome PROTECT readmission recruited registration number required rescue secondary secondary outcome Secondary outcomes Steroids Stool culture subsequent surgery surgery for IBD therapy Treatment Treatment outcome ulcerative colitis used data [DOI] 10.1136/bmjgast-2021-000763 PMC 바로가기 [Article Type] Multicenter Study
Education case: a case-based approach to overlap syndromes in autoimmune liver disease in patient with ulcerative colitisMedical Education Published on 2022-01-012024-09-04 Journal: Gastroenterology and Hepatology From Bed to Bench [Category] 대상포진, [키워드] Autoimmune hepatitis Inflammatory bowel disease overlap syndrome primary sclerosing cholangitis ulcerative colitis [DOI] 10.22037/ghfbb.v15i3.2332 PMC 바로가기 [Article Type] Medical Education
COVID-19 Vaccine Hesitancy among Patients with Inflammatory Bowel Disease Receiving Biologic Therapies in Kuwait: A Cross-Sectional StudyArticle Published on 2021-12-312022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] addition age biologic biologics BMI BNT162b2 Care ChAdOx1 nCoV-19 conducted COVID-19 COVID-19 vaccination COVID-19 vaccine Crohn’s disease cross-sectional death diagnosed effective Efficacy enrolled evaluate Expatriate Express female gastroenterology General population Health Organization Hesitancy Hospitalization IBD Inflammatory bowel disease infliximab Kuwait male median age no statistical difference Patient patients physician Prevalence prevalence of COVID-19 Primary outcome receive receiving recruitment reducing retrieved risk Safe secondary outcome Severe infection Sex shown single-center the vaccine Therapies therapy ulcerative colitis vaccination Vaccine vedolizumab WHO [DOI] 10.3390/vaccines10010055 PMC 바로가기 [Article Type] Article
Jakinibs of All Trades: Inhibiting Cytokine Signaling in Immune-Mediated PathologiesReview Published on 2021-12-302022-10-28 Journal: Pharmaceuticals [Category] COVID-19, [키워드] allergic diseases allogeneic transplantation approved Arthritis atopic dermatitis Autoimmune Autoimmune diseases clinical development Coronavirus disease-19 country COVID-19 Cytokine storm Cytokines disease Diseases Efficacy expand graft-versus-host-disease GVHD Hospitalized Hyperinflammatory immune Inflammation inflammatory disorders inflammatory pathology investigated Jak JAK inhibitor Janus kinase late phase limit Multiple over patients pharmacokinetic potential benefit profiles selective shown Treatment ulcerative colitis while [DOI] 10.3390/ph15010048 PMC 바로가기 [Article Type] Review
Treatment of Inflammatory Bowel Disease: A Comprehensive ReviewReview Published on 2021-12-202024-09-02 Journal: Frontiers in Medicine [Category] 대상포진, [키워드] Crohn disease Inflammatory bowel disease recent advance Therapeutics ulcerative colitis [DOI] 10.3389/fmed.2021.765474 PMC 바로가기 [Article Type] Review
The physiological and psychological effects of cognitive behavior therapy on patients with inflammatory bowel disease before COVID-19: a systematic reviewResearch Published on 2021-12-152022-10-27 Journal: BMC Gastroenterology [Category] Coronavirus, Fulltext, SARS, [키워드] Anxiety C-reactive protein CBT CINAHL clinical trial cognitive Cognitive behavior therapy cognitive behavioral therapy Consensus Crohn's disease Depression Disease activity Effect eligible evaluate Evidence IBD IMPROVE inclusion criteria Inflammatory bowel disease initial Mental objective outcome Patient patients physical physiological positive post-intervention Psychological psychological improvement PsycINFO Quality of life Randomized controlled trial RCT reduce Result searched shown supplementary material sustained systematic review therapy Treatment ulcerative colitis Web of Science [DOI] 10.1186/s12876-021-02003-0 PMC 바로가기 [Article Type] Research
Serological Response to BNT162b2 and ChAdOx1 nCoV-19 Vaccines in Patients with Inflammatory Bowel Disease on Biologic TherapiesArticle Published on 2021-12-132022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] adalimumab age anti-SARS-CoV-2 anti-SARS-CoV-2 IgG antibody biologic biologic therapies BNT162b2 BNT162b2 vaccine ChAdOx1 nCoV-19 ChAdOx1 nCoV-19 vaccine Concentration COVID-19 Crohn’s disease dose effective enrolled evaluate first dose follow-up study IBD immunogenicity Inflammatory bowel disease infliximab majority neutralizing antibody occur of BNT162b2 Patient performed positive proportion Prospective Study receiving response SARS-CoV-2 antibody SARS-CoV-2 IgG SARS-CoV-2 vaccination SARS-CoV-2 vaccine second dose seroconverted serological response the vaccine Therapies therapy treated ulcerative colitis ustekinumab vaccination Vaccine Vaccines vedolizumbab [DOI] 10.3390/vaccines9121471 PMC 바로가기 [Article Type] Article